Cargando…

Cuproptosis-Related LncRNA-Based Prediction of the Prognosis and Immunotherapy Response in Papillary Renal Cell Carcinoma

Cuproptosis, a new cell death pattern, is promising as an intervention target to treat tumors. Abnormal long non-coding RNA (lncRNA) expression is closely associated with the occurrence and development of papillary renal cell carcinoma (pRCC). However, cuproptosis-related lncRNAs (CRLs) remain large...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pang, Yipeng, Wang, Yushi, Zhou, Xinyu, Ni, Zhu, Chen, Wenjing, Liu, Yi, Du, Wenlong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863050/ https://www.ncbi.nlm.nih.gov/pubmed/36674979 http://dx.doi.org/10.3390/ijms24021464

Ejemplares similares

Cuproptosis-related lncRNA signatures predict prognosis and immune relevance of kidney renal papillary cell carcinoma
por: Xie, Tongjin, et al.
Publicado: (2022)

The LncRNA signature associated with cuproptosis as a novel biomarker of prognosis in immunotherapy and drug screening for clear cell renal cell carcinoma
por: Zhang, Lishuo, et al.
Publicado: (2023)

Identification and Validation of Cuproptosis-Related LncRNA Signatures in the Prognosis and Immunotherapy of Clear Cell Renal Cell Carcinoma Using Machine Learning
por: Bai, Zhixun, et al.
Publicado: (2022)

Cuproptosis-related lncRNA: Prediction of prognosis and subtype determination in clear cell renal cell carcinoma
por: Huili, Youlong, et al.
Publicado: (2022)

A cuproptosis-related lncRNA signature for predicting prognosis and immunotherapy response of lung adenocarcinoma
por: Yu, Sheng, et al.
Publicado: (2023)

Potential Role of Cuproptosis-Related Lncrna in Prognosis and Immunotherapy of Thyroid Carcinoma
por: Cai, Yunying, et al.
Publicado: (2023)

Significance of cuproptosis‐related lncRNA signature in LUAD prognosis and immunotherapy: A machine learning approach
por: Yang, Lihong, et al.
Publicado: (2023)

A novel Cuproptosis-related LncRNA signature to predict prognosis in hepatocellular carcinoma
por: Zhang, Genhao, et al.
Publicado: (2022)

Development and validation of cuproptosis-related lncRNA signatures for prognosis prediction in colorectal cancer
por: Pang, Lin, et al.
Publicado: (2023)

Identification and validation of a novel cuproptosis-related lncRNA signature for prognosis and immunotherapy of head and neck squamous cell carcinoma
por: Xu, Qiu-Shuang, et al.
Publicado: (2022)

A Noval Established Cuproptosis-Associated LncRNA Signature for Prognosis Prediction in Primary Hepatic Carcinoma
por: Luo, Lan, et al.
Publicado: (2022)

Cuproptosis-Associated lncRNA Establishes New Prognostic Profile and Predicts Immunotherapy Response in Clear Cell Renal Cell Carcinoma
por: Xu, Shengxian, et al.
Publicado: (2022)

Construction of a Prognostic Model Based on Cuproptosis-Related lncRNA Signatures in Pancreatic Cancer
por: Jiang, Wenkai, et al.
Publicado: (2022)

Comprehensive analysis of a novel cuproptosis-related lncRNA signature associated with prognosis and tumor matrix features to predict immunotherapy in soft tissue carcinoma
por: Liu, Binfeng, et al.
Publicado: (2022)

Cuproptosis-Related LncRNA Signature for Predicting Prognosis of Hepatocellular Carcinoma: A Comprehensive Analysis
por: Chen, Qiqi, et al.
Publicado: (2022)

A cuproptosis-related lncRNA signature for predicting prognosis and immune response in hepatocellular carcinoma
por: Wu, Jingyi, et al.
Publicado: (2023)

Identification of cuproptosis‐related lncRNAs for prognosis and immunotherapy in glioma
por: Wang, Lin, et al.
Publicado: (2022)

Cuproptosis-related lncRNA predict prognosis and immune response of lung adenocarcinoma
por: Wang, Fangwei, et al.
Publicado: (2022)

A cuproptosis-related lncRNA signature identified prognosis and tumour immune microenvironment in kidney renal clear cell carcinoma
por: Xin, Sheng, et al.
Publicado: (2022)

Prediction of the Prognosis of Clear Cell Renal Cell Carcinoma by Cuproptosis-Related lncRNA Signals Based on Machine Learning and Construction of ceRNA Network
por: Xiao, Zhiliang, et al.
Publicado: (2023)

Construction of lncRNA prognostic model related to cuproptosis in esophageal carcinoma
por: Zhang, Liming, et al.
Publicado: (2023)

Bioinformatics prediction and experimental verification identify cuproptosis-related lncRNA as prognosis biomarkers of hepatocellular carcinoma
por: Liangyu, Zhu, et al.
Publicado: (2023)

Construction of a cuproptosis‐related lncRNA signature for predicting prognosis and immune landscape in osteosarcoma patients
por: Ni, Shumin, et al.
Publicado: (2022)

Identification of cuproptosis-related lncRNA for predicting prognosis and immunotherapeutic response in cervical cancer
por: Kong, Xiaoyu, et al.
Publicado: (2023)

Construction of a cuproptosis-associated lncRNA prognostic signature for bladder cancer and experimental validation of cuproptosis-related lncRNA UBE2Q1-AS1
por: Shen, Junlin, et al.
Publicado: (2023)

A novel cuproptosis-related lncRNA nomogram to improve the prognosis prediction of gastric cancer
por: Feng, Anqi, et al.
Publicado: (2022)

A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA
por: Yang, Mingyi, et al.
Publicado: (2022)

Prognosis and immune response of a cuproptosis-related lncRNA signature in low grade glioma
por: Xu, Yifan, et al.
Publicado: (2022)

Construction and validation of a cuproptosis-related lncRNA signature for the prediction of the prognosis of LUAD and LUSC
por: Wang, Yu, et al.
Publicado: (2023)

Development and Evaluation of a Novel Cuproptosis-Related lncRNA Signature for Gastric Cancer Prognosis
por: Yin, Chunlin, et al.
Publicado: (2023)

A cuproptosis-related lncRNA signature to predict prognosis and immune microenvironment of colon adenocarcinoma
por: Li, Dongming, et al.
Publicado: (2023)

Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma
por: Liu, Binfeng, et al.
Publicado: (2022)

Cuproptosis-related lncRNA SNHG16 as a biomarker for the diagnosis and prognosis of head and neck squamous cell carcinoma
por: Han, Baoai, et al.
Publicado: (2023)

A Novel Ferroptosis-Related lncRNA Signature for Prognosis Prediction in Patients with Papillary Renal Cell Carcinoma
por: Dang, Ruijie, et al.
Publicado: (2022)

Downregulation of lncRNA SDPR-AS is associated with poor prognosis in renal cell carcinoma
por: Ni, Wenjun, et al.
Publicado: (2017)

Bioinformatics analysis and experimental validation of cuproptosis-related lncRNA LINC02154 in clear cell renal cell carcinoma
por: Shen, Junlin, et al.
Publicado: (2023)

A novel cuproptosis-related lncRNA signature predicts the prognosis and immune landscape in bladder cancer
por: Bai, Yuchen, et al.
Publicado: (2022)

Cuproptosis-related lncRNA signatures: Predicting prognosis and evaluating the tumor immune microenvironment in lung adenocarcinoma
por: Zhang, Pengpeng, et al.
Publicado: (2023)

A novel cuproptosis-related lncRNA signature to predict prognosis and immune landscape of lung adenocarcinoma
por: Wang, Xinyi, et al.
Publicado: (2023)

A novel cuproptosis-related lncRNA signature predicts prognosis and therapeutic response in bladder cancer
por: Cai, Jinming, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_big8cobqo5cjiv61paut2jf5je